[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wegro_app Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1787088114588209152.png) Wegro App [@wegro_app](/creator/twitter/wegro_app) on x 10.2K followers
Created: 2025-07-14 13:06:37 UTC

Divi's Laboratories (Divi's) announced its 35th Annual General Meeting (AGM) and Annual Report for FY25. 🚀

- 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:
    ▪ The company focuses on creating a meaningful impact and pushing boundaries in Active Pharmaceutical Ingredient (API) development and manufacturing.
    ▪ The AGM notice and annual report for the financial year 2024-25 have been released.
    ▪ The company is committed to scientific excellence and innovation.
    ▪ Commercial operations have commenced from a section of Phase 1, Unit X Greenfield project at Kakinada, Andhra Pradesh.
    ▪ Successful US FDA inspection at Unit X manufacturing facility, reinforcing their commitment to high regulatory standards and compliance. 🔬

- 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗙𝗼𝗰𝘂𝘀:
    ▪ Divi's Laboratories focuses on generics, custom synthesis, and nutraceuticals. 💰
    ▪ The company is committed to maintaining product leadership and pursue new opportunities.

- 𝗘𝗦𝗚 𝗖𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁:
    ▪ Strong emphasis on Environmental, Social, and Governance (ESG) principles. 🌍
    ▪ Commitment to building a greener planet, promoting ecological balance, strengthening communities, and empowering its employees. 🔬

📊 DIVI`S LABORATORIES LTD | 🏷️ Reg. XX (1) Annual Report

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944745350235082854/c:line.svg)

**Related Topics**
[$divislabbo](/topic/$divislabbo)

[Post Link](https://x.com/wegro_app/status/1944745350235082854)